Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

TRIF/TICAM1 Antibody, Novus Biologicals™
SDP

Rabbit Polyclonal Antibody

Supplier:  Novus Biologicals NBP312427

Catalog No. NB186577


Only null left
Add to Cart
This item is not returnable. View return policy

Description

Description

TRIF/TICAM1 Polyclonal antibody specifically detects TRIF/TICAM1 in Human, Mouse, Rat samples. It is validated for Western Blot, ELISA
Specifications

Specifications

TRIF/TICAM1
Polyclonal
Western Blot 1:500-1:750, ELISA 1:20000
MGC35334, Proline-rich, vinculin and TIR domain-containing protein B, PRVTIRBTIR domain-containing adapter protein inducing IFN-beta, Putative NF-kappa-B-activating protein 502H, TICAM-1TIR domain containing adaptor inducing interferon-beta, TIR domain-containing adapter molecule 1, TIR domain-containing adaptor molecule 1, toll-like receptor adaptor molecule 1, TRIFToll-interleukin-1 receptor domain-containing adapter protein inducinginterferon beta
Synthetic peptide taken within amino acid region 150-199 on human E3 ubiquitin-protein ligase RNF138 protein.
100 μg
Signal Transduction
148022
Store at 4°C short term. Store at -20°C long term. Avoid freeze-thaw cycles.
Western Blot, ELISA
Unconjugated
Contains Tris, HCl/glycine buffer (pH 7.4-7.8), 30% glycerol, 0.5% BSA, along with cryo-protective agents, and HEPES (exact storage and stabilization buffer information is proprietary) with 0.02% Sodium Azide
Rabbit
Affinity-purified
RUO
Primary
Human, Mouse, Rat
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.